
Wells Fargo raised the firm’s price target on Cardinal Health (CAH) to $321 from $277 and keeps an Overweight rating on the shares. The firm cites strong Q1 2027 results
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CAH | Cardinal Health | 283.15 | 79.40 | 38.97% |
| Name | Price | % Change | |
|---|---|---|---|
| $283.15 | +38.97% |

Wells Fargo raised the firm’s price target on Cardinal Health (CAH) to $321 from $277 and keeps an Overweight rating on the shares. The firm cites strong Q1 2027 results

Cardinal Health ( ($CAH) ) just unveiled an announcement. Cardinal Health, Inc. held its 2026 Annual Meeting of Shareholders on November 12, 2026. Shareholders elected 11 nominees to the Board

Argus raised the firm’s price target on Cardinal Health (CAH) to $309 from $264 and keeps a Buy rating on the shares. The firm is maintaining a positive view of

JPMorgan analyst Lisa Gill raised the firm’s price target on Cardinal Health (CAH) to $286 from $260 and keeps a Neutral rating on the shares. Published first on TheFly –

TD Cowen analyst Charles Rhyee raised the firm’s price target on Cardinal Health (CAH) to $304 from $280 and keeps a Buy rating on the shares. The firm updated its

Cardinal Health (($CAH)) has held its Q1 earnings call. Read on for the main highlights of the call. Cardinal Health delivered a strongly positive first-quarter earnings call, marked by broad-based

JPMorgan holds a post 3Q earnings conference call with management on November 6 at 2 pm. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving breaking

RBC Capital analyst Ryan Halsted raised the firm’s price target on Cardinal Health (CAH) to $295 from $276 and keeps an Outperform rating on the shares. The firm cites the

UBS raised the firm’s price target on Cardinal Health (CAH) to $310 from $295 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source

Morgan Stanley raised the firm’s price target on Cardinal Health (CAH) to $306 from $286 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Assigned | Nov 17, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| hold | Reiterated | Nov 10, 2026 | ||||
| buy | Assigned | Nov 9, 2026 | ||||
| buy | Assigned | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Assigned | Nov 5, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 4, 2027TBA | $65.61B | $3.13 | $68.30B | 2.68 | 36.58 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.